The purpose of this task order is to fund the guaranteed minimum amount of the contract.
Ended Awarded Last action
- Contract number
- 75N93021F00001
- Awardee
-
University Of Texas Medical Branch At Galveston UEI MSPWVMXXMN76 Part of University Of Texas System
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $0
Award facts
- Opportunity
-
- Preclinical Services for HIV Therapeutics Pre-Solicitation · 75N93019R00021 · Posted Oct 4, 2019
- Preclinical Services for HIV Therapeutics Award Notice · Posted Oct 20, 2020
- Preclinical Services for HIV Therapeutics Solicitation · Posted Dec 5, 2019
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Galveston, TX 77555, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$2,500 | |
| Original award | $2,500 |
About this award
This delivery order against the Preclinical Services for HIV Therapeutics master IDIQ, awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to the University of Texas Medical Branch at Galveston, funds the guaranteed minimum amount of $0.00 under the contract. As the parent organization of the awardee, the University of Texas System will also support this work. The completion date is May 28, 2021 and the place of performance will be in Galveston, Texas. No set-aside designation was used for this award to support preclinical research services that can help advance the development of therapeutics to treat HIV/AIDS.
Quick answers
Who was awarded contract 75N93021F00001?
75N93021F00001 was awarded to University Of Texas Medical Branch At Galveston by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on October 15, 2020.
How much is contract 75N93021F00001 worth?
The government has obligated $0 on 75N93021F00001.
Is contract 75N93021F00001 an order under another contract?
Yes. 75N93021F00001 is a delivery order under 75N93021D00011, an indefinite delivery contract, on Preclinical Services for HIV Therapeutics.
Was contract 75N93021F00001 competed?
The extent of competition for 75N93021F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award